Adaptin Bio APTN
OTC APTN
$6.27 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

Adaptin Bio, Inc. (APTN) Cash from Operations (2023 - 2026)

Updated

Adaptin Bio (APTN) posted Cash from Operations of -$450,164 for Q2 2026, compared with -$1.02 million a year earlier.

Analysis

Adaptin Bio, Inc. (APTN) Cash from Operations (2023 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Cash from Operations at Adaptin Bio was -$2.52 million; for FY2025, it came in at -$4.78 million.

  • In prior years, Adaptin Bio's Cash from Operations was -$649,283 in FY2024, -$81,035 in FY2023 and -$304.00 in FY2022.
  • The Q2 2026 figure stands as the highest quarterly Cash from Operations since Q4 2024.
  • According to Business Quant data, Cash from Operations for the three prior quarters was -$596,298 (Q1 2026), -$702,876 (Q4 2025) and -$772,430 (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -450,164.00
Mar 31, 2026 -596,298.00
Dec 31, 2025 -702,876.00
Sep 30, 2025 -772,430.00
Jun 30, 2025 -1.02 Mn
Mar 31, 2025 -2.28 Mn
Dec 31, 2024 112,653.00
Sep 30, 2024 -468,416.00
Jun 30, 2024 -203,825.00
Mar 31, 2024 -89,695.00
Dec 31, 2023 -58,347.00
API Access

Adaptin Bio, Inc. Cash from Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-operations&ticker=APTN&period=max&api_key=YOUR_API_KEY